..Information to Pharmacists
    _______________________________

    Your Monthly E-Magazine
    SEPTEMBER, 2002

    Published by Computachem Services

    P.O Box 297.
    Alstonville. 2477
    NSW Australia

    Phone:
    61 2 66285138

    E-Mail
    This
    Page
    Click For a
    Printer-Friendly
    Page
    Bookmark
    This Page

    KARALYN HUXHAGEN

    PSA Councilor Perspective

    Paracetamol and Supermarkets

    The recent case of a teenage boy dying from complications of acute paracetamol toxicity has brought questions from the coroner on how easy it is to die from a simple pain relieving medication
    "A coroner is expected to recommend that paracetamol be removed from supermarket shelves and sold only in pharmacies, after a teenage boy died from an overdose of the drug.
    Wade Dunn, 13, was administered 31 grams of paracetamol over 14 days in two NSW hospitals while convalescing from a routine procedure.
    Draft recommendations circulated by the coroner Jan Stevenson to lawyers involved in Wade's inquest ask the NSW Department of Health to consider restricting the availability of paracetamol products to pharmacies.
    The recommendations, referred to in written submissions made to Orange Local Court yesterday, also call for a committee of experts to review the current "use and abuse of paracetamol, to establish realistic guidelines in order to prevent the potential for liver failure in children".

    Don Robertson, president of the paediatrics and child health division of the Royal Australasian College of Physicians, said that rather than restricting the drug's sale, he would support more safety information to be made available where it was sold.
    "Under almost all circumstances [paracetamol] is helpful and safe," Dr Robertson said. "But we do need to recognise that when it is taken in high doses it can have adverse effects."

    In earlier evidence, a gastroenterologist, Dr Edward O'Loughlin, called for stronger warnings on packets of the drug, recommending patients were reviewed after 48 hours' treatment."
    Even though this case looks like a hospital based drug misadventure, the coroner has made several recommendations including restricting the sale of Paracetamol products to Pharmacies.
    This then begs the question- is Pharmacy any better situated in offering advice and counselling with the sale of Paracetamol products than the 'checkout' chick at Coles?
    How many OTC sales of Paracetamol 24 tablets does the Pharmacist personally supervise?
    How many times does the Pharmacist/ senior pharmacy assistant counsel the patient on the potential for additive effects if this product is taken with several of the cough and cold or headache medications?
    In some States, the consumers can access the Paracetamol easily and there is no staff intervention-where is the point of difference occurring that would make it better for these products to be sold only in Pharmacies?
    I do not think restricting the sale only to Pharmacies is the complete answer.
    There also needs to be a major consumer awareness campaign on the dangers of long term and large dose usage of Paracetamol as well as a campaign on the dangers of mixing medications.
    This may be an area that organizations such as NPS can play a part when developing their 'key message' strategies for public health campaigns such as the Cough and Cold campaign.
    With many proprietary cough and cold medications already containing paracetamol there is potential for toxic doses to be ingested.
    Cough and cold season is when this is more likely to occur and maybe this needs to be a key message when training our Pharmacy staff on professional counselling in S2/S3 sales. Manufacturers need to place warnings on the boxes about the recommended daily dosing of ALL paracetamol and the warning should extend to how long to use the product before seeking medical advice.

    Pharmacy is an excellent source of health information and we are able to retain our customers by delivering good service backed by good evidence based information.
    It is vital that we do not lose sight of the fact that some of the more common and older medications we sell can cause harm.
    When developing your protocols for your staff on the counselling and sales for products in the S2/S3 section, it is prudent to remind them it is not only the large pack size users who are at risk consumers.
    All consumers have the potential to 'mix' products and to take three tablets four times a day as a 'little bit more' is always better.
    The point of difference between Pharmacy and the supermarket is the specialised training of the pharmacy staff and the time taken to deliver the important messages to the consumer.
    Pharmacy staff should also be aware that consumers rarely read all of the messages printed on a product box or in the leaflet so it is vital to reiterate the important messages at the point of sale.
    The PSA document'Standards for the Provision of Pharmacist Only and Pharmacy Medicines in Community Pharmacy' (see www.psa.org.au) was developed in response to the emerging awareness of the need for community Pharmacy to protect their unique position as being the major provider of these products. Community Pharmacies employ professional Pharmacists supported by well trained assistants and they operate in an environment that is conducive to providing accurate information to the consumers.
    It is absolutely important that all Pharmacists read this document and implement its guidelines if we are going to provide the point of difference to the consumers.
    This document is a vital part of the QCPP process and adherence to the standards of the Quality Care Pharmacy Program is one sure way that Pharmacy can show that it is a certainly a better place to sell Paracetamol products than supermarkets will ever be.

    Back to Front Page